Telomerase-Activated Fertility Enhancement Systems

This inventive concept integrates telomerase-activating compounds with advanced technologies like AI, IoT, blockchain, and microRNA-based diagnostics to create a comprehensive fertility enhancement system, providing personalized treatment and monitoring for improved fertility outcomes.

The original patent disclosed telomerase-activating compounds for fertility applications, but it lacked a comprehensive system for personalized treatment and monitoring. This new inventive concept addresses this limitation by integrating the compounds with advanced technologies to provide a more effective and personalized fertility enhancement system.

The inventive concept comprises four main components: (1) telomerase-activating compounds, (2) AI-based fertility prediction algorithms, (3) microRNA-based fertility diagnostic modules, and (4) blockchain-based fertility data management platforms. These components work together to provide personalized fertility treatment and monitoring. The AI algorithm analyzes genomic data to identify optimal treatment regimens and predict treatment outcomes. The microRNA-based diagnostic module monitors telomerase expression and activity in gonadal or fertility-associated cells and tissues. The blockchain-based platform securely stores and shares fertility-related data, ensuring secure and personalized fertility treatment. Additionally, the system may incorporate IoT-enabled wearable devices for tracking fertility-related biomarkers and low-level laser therapy to stimulate telomerase expression and activity.

The new claims introduce a synergistic combination of telomerase-activating compounds with advanced technologies like AI, IoT, blockchain, and microRNA-based diagnostics, providing a comprehensive fertility enhancement system that is not obvious from the original patent. The inventive step lies in the integration of these components to provide personalized fertility treatment and monitoring, which is not disclosed in the original patent.

Alternative embodiments of the inventive concept may include using different AI algorithms, varying the types of microRNA-based diagnostic modules, or incorporating other advanced technologies like nanotechnology or gene editing. The system may also be adapted for use in different fertility-related applications, such as fertility preservation or fertility-related research.

The inventive concept has significant commercial potential in the fertility industry, with a growing market for personalized fertility treatment and monitoring solutions. The system may be marketed to fertility clinics, research institutions, and individuals seeking fertility treatment. The integration of advanced technologies like AI, IoT, and blockchain may also attract investors and partners from the healthcare and technology sectors.